1st Quarter - Report

ARTEMIS POLICY GROUP LLC for NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION)

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Implementation of H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 of the Social Security Act; policies related to work requirements in Medicaid Comments on RE: CMS-5545-P: Global Benchmark for Efficient Drug Pricing (GLOBE) Model Comments on CMS-5546-P: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model

LobbyistCovered position, as disclosed
LESLIE BRADY Health Policy Advisor/Legislative Assistant, Rep. Brian Higgins
MIRIAM GOLDSTEIN New —
JOHANNA GRAY Intern, Senator Barack Obama

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 1 (119th)

Health Issues HCR

Blood and plasma safety and awareness Bleeding disorders awareness

LobbyistCovered position, as disclosed
LESLIE BRADY Health Policy Advisor/Legislative Assistant, Rep. Brian Higgins
MIRIAM GOLDSTEIN New —
JOHANNA GRAY Intern, Senator Barack Obama

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Insurance INS

Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834 Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)

LobbyistCovered position, as disclosed
LESLIE BRADY Health Policy Advisor/Legislative Assistant, Rep. Brian Higgins
MIRIAM GOLDSTEIN New —
JOHANNA GRAY Intern, Senator Barack Obama

Contacted: Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Treasury, Dept of; SENATE

Bills named: S. 864 (119th), H.R. 1834 (119th), H.R. 247 (119th), H.R. 1 (119th), H.R. 5371 (119th), H.R. 6423 (119th)

Budget/Appropriations BUD

Funding for federal hemophilia programs in FY26 and FY27 House and Senate Labor-HHS Appropriations bills NIH FY26 and FY27 appropriations

LobbyistCovered position, as disclosed
LESLIE BRADY Health Policy Advisor/Legislative Assistant, Rep. Brian Higgins
MIRIAM GOLDSTEIN New —
JOHANNA GRAY Intern, Senator Barack Obama

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program

LobbyistCovered position, as disclosed
LESLIE BRADY Health Policy Advisor/Legislative Assistant, Rep. Brian Higgins
MIRIAM GOLDSTEIN New —
JOHANNA GRAY Intern, Senator Barack Obama

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Hemophilia research, prevention, surveillance and service programs and issues; advancing care for women and girls with bleeding disorders

LobbyistCovered position, as disclosed
LESLIE BRADY Health Policy Advisor/Legislative Assistant, Rep. Brian Higgins
MIRIAM GOLDSTEIN New —
JOHANNA GRAY Intern, Senator Barack Obama

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.